Evotec AG announced that Evotec has entered into a multi-year compound management agreement with the United States EPA. The contract covers a period of five years and has a total value of up to EUR7.7 million (approx. USD 10 million).
Under the agreement Evotec, through its San Francisco operations, will provide chemical procurement, analysis, sample preparation, and management services in support of the EPA's National Computational Center for Toxicology (NCCT). Services provided will support bioactivity profiling of the EPA's ToxCast(TM) (Prioritization of Environmentally Relevant Chemicals) Compound Library.
Dr Mario Polywka, Chief Operating Officer of Evotec, commented: "We are very pleased that the United States EPA has again chosen Evotec to manage its compound collection in support of the National Computational Center for Toxicology (NCCT). This follows from our initial contract with the EPA signed in 2007. Providing key, efficient scientific infrastructures such as Compound Management is a key element of Evotec Execute and we look forward to supporting the EPA's ongoing effort to predict potential toxicity of environmental chemicals. This contract provides further long-term revenue and profitability for Evotec's important compound management services in San Francisco which was acquired from BioFocus in 2011."
Evotec and Dow AgroSciences announce collaboration on Cellular Target Profiling
Evotec AG announced that Evotec and Dow AgroSciences (DOW) have entered into a research collaboration with the objective of leveraging Evotec's chemical proteomics services to support compounds in development at Dow AgroSciences. To this end, Evotec will perform chemical proteomics services ... more
Evotec to realign Discovery Chemistry Operations
Evotec AG announced that it will close its Chemistry Operations in Thane, India. All chemistry efforts will now be performed at its Abingdon (UK) facility, answering to an increasing requirement to operate closer to the principal R&D laboratories of our major customers. All project work in ... more
PerkinElmer Completes Acquisition of Euroscreen Products SA And Evotec Technologies
PerkinElmer, Inc. reported that it has successfully completed two previously announced acquisitions that will extend its portfolio of advanced tools for cellular analysis and High Content Screening (HCS). In the fourth quarter of 2006, the Company announced its intent to acquire Euroscreen ... more
Evotec is a leader in the discovery and development of novel small molecule drugs with operational sites in Europe and Asia. The Company has built substantial drug discovery expertise and an industrialised platform that can drive new innovative small molecule compounds into the clinic. In a ... more
Substantial improvements made in EPA’s IRIS program
A new congressionally mandated report from the National Research Council says that changes EPA has proposed and implemented into its Integrated Risk Information System (IRIS) process are “substantial improvements.” While acknowledging the progress made to date, the report offers further gui ... more
Super-sensitive detection of asbestos in soil samples
A new method of sample preparation, developed by a group of US scientists, promises to increase the sensitivity of asbestos analysis 100-fold, to the point where it can be used to detect the substance in soil. Although at a low level, asbestos contamination in soil is of potential concern. ... more
Bayer CropScience is strengthening its crop protection portfolio further
The non-selective herbicide Alion® (active ingredient indaziflam) from Bayer CropScience has been granted regulatory approval in the United States by the Environmental Protection Agency (EPA). Alion® was developed primarily for use in perennial crops such as citrus, tree nut, grapes, pome a ... more
